Regional Strategy
To Stop Tuberculosis
in the Western Pacific

A Strong Collaboration

The support from our partners and donors has been instrumental throughout the process of Regional Strategy development, and is even more critical now in the implementation stage.  The US Agency for International Development (USAID), Japan and Korea are the primary sources of financial support for both staff and activities.  Aside from these key donors, close collaboration with many other technical partners is an integral part of WHO work to strengthen TB control in the Region. 

The Supranational Reference Laboratories (RIT, KIT, QMRL, IMVS and the Mycobacterium Laboratory in Hong Kong) provide fundamental technical support to countries for sputum culture and Drug Sensitivity Testing (DST), as well as overall recommendations for laboratory strengthening.  Other partners specialize in certain areas, such as MDR-TB, TB/HIV co-infection, Infection Control, Information systems, Advocacy, Communication and Social Mobilization (ACSM), migrants and vulnerable groups, etc.  Of course, we also work closely with the National TB Programmes in all TB high-burden countries without which this Region would not have made such remarkable progress in TB control.

We thank each and every one of our partners for their continued support and collaborative efforts as we strive for a Region Free of TB.